Recombinant pre-S antigen hepatitis B vaccine (Chengdu institute of biological products)
含前S抗原重组乙型肝炎疫苗（成都生物制品研究所）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant pre-S antigen hepatitis B vaccine (Chengdu institute of biological products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesChengdu Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A